Русский
Nederlandse taal
Deutsch
Francés
한국어
Português
Español
日本語
ไทย
PCL HA Dermal Filler
Ingredient: Polycaprolactone 10%, Cross linked hyaluronic acid 24mg/ml
Specification: 1ml
Package: Single package
Application Area: Used for nose, jaw, lacrimal groove, temple, outer contour and other subcutaneous deep or shallow injection.
Product Introduction：
Our product stands out with its high elastic modulus, providing excellent viscoelasticity and superior shape retention while preventing migration. With an increased HA concentration and a diverse range of options, it can be tailored to various treatment objectives and facial areas for the most natural results. The microsphere composition affects degradation speed, with PCL microspheres ensuring extended longevity compared to block copolymer microspheres. Its broad scope of application includes enhancements for the nose, jawline, tear troughs, and temples.
Product Display：
Product Details:
Type | PCL-HA Filler |
Ingredient | Polycaprolactone 10%, Cross linked hyaluronic acid 24mg/ml |
Specification | 1ml |
Effect area | The deep dermis, superficial subcutaneous and deep layers were filled by injection |
Application area | Used for nose, jaw, lacrimal groove, temple, outer contour and other subcutaneous deep or shallow injection |
How to choose | Moderate to severe naso-lip wrinkles |
Package | Single package |
Storage | Cool, dry environment |
Recommended | 1-2 pc/time |
Recommended interval | 12 months |
Lasting time | 12 months |
Microsphere size | The median particle size was 32±6μm, and more than 95% of the microspheres were between 25 and 50μm |
Product Package:
Customer Feedback：
Raw Material Advantages：
Designed with an injection force of only 12N—far lower than the industry standard of 20N—this formulation ensures easier administration and shorter treatment times for medical professionals and patients alike. Thanks to its exceptional viscoelasticity, it effectively improves facial features such as the nasal base, brow ridge, and outer contours. With an HA concentration of 20-24 mg/g, it provides multiple formulation options, customizable to meet specific needs. The choice of microspheres affects degradation duration, with PCL microspheres delivering longer-lasting results than block copolymer microspheres. Its extensive application includes nose contouring, jawline enhancement, tear trough filling, and temple augmentation.
Development Process:
Company Introduction:
This product's lower injection force of 12N, compared to the standard 20N, ensures a smoother and more effortless application, shortening procedure times for doctors and patients. With remarkable viscoelasticity, it is highly effective in enhancing the nasal base, brow ridge, and outer facial contours. Containing 20-24 mg/g of HA, it provides more options and customization flexibility. The degradation time and rate depend on the microsphere type, with PCL microspheres offering a longer duration of action than block copolymer microspheres. Its broad application includes the nose, chin, tear troughs, temples, and other facial areas.
